Identifying an immunogenic cell death-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma

CONCLUSIONS: The molecular subtypes and a risk model based on ICDGs proposed in our study are both promising prognostic classifications in LUAD, which may provide novel insights for developing accurate targeted cancer therapies.PMID:38575204 | DOI:10.18632/aging.205705

Source: Aging - April 4, 2024 Category: Biomedical Science Authors: Xue Li Dengfeng Zhang Pengfei Guo Shaowei Ma Shaolin Gao Shujun Li Yadong Yuan Source Type: research